Compare RGNX & PGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGNX | PGC |
|---|---|---|
| Founded | 2008 | 1921 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.5M | 769.6M |
| IPO Year | 2015 | 1997 |
| Metric | RGNX | PGC |
|---|---|---|
| Price | $7.45 | $46.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | $23.58 | ★ $56.00 |
| AVG Volume (30 Days) | ★ 1.3M | 92.3K |
| Earning Date | 11-09-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 0.43% |
| EPS Growth | ★ 18.08 | 13.51 |
| EPS | N/A | ★ 1.65 |
| Revenue | $10,393,000.00 | ★ $282,995,000.00 |
| Revenue This Year | N/A | $24.36 |
| Revenue Next Year | $23.50 | $12.76 |
| P/E Ratio | ★ N/A | $27.93 |
| Revenue Growth | ★ 126.48 | 24.05 |
| 52 Week Low | $5.46 | $24.71 |
| 52 Week High | $16.19 | $49.14 |
| Indicator | RGNX | PGC |
|---|---|---|
| Relative Strength Index (RSI) | 50.22 | 60.63 |
| Support Level | $6.96 | $44.32 |
| Resistance Level | $8.31 | $47.32 |
| Average True Range (ATR) | 0.43 | 0.96 |
| MACD | 0.06 | 0.34 |
| Stochastic Oscillator | 55.77 | 77.69 |
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
Peapack Gladstone Financial Corp is a bank holding company. Through its subsidiaries, the company offers various wealth management, investment banking, and commercial and personal banking solutions to its clients. The company has two reportable segments: Banking, which generates the maximum revenue, and Wealth Management. The Banking segment includes commercial, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; escrow management; deposit generation; operation of ATMs; telephone and internet banking services; credit card services, etc. The Wealth Management segment offers investment management services for individuals and institutions; personal trust services; and other financial planning and advisory services.